Effects of fatty acid glycerol esters on intestinal absorptive and secretory transport of ceftibuten

Biological and Pharmaceutical Bulletin

Volumn 22, Issue 4, 1999, Pages 402-406

  Koga, Kenjiro ^a   Murakami, Masahiro ^b   Kawashima, Susumu ^a  

^a HOKURIKU UNIVERSITY   (Japan)

^b Research Department   (Japan)

Author keywords

Ceftibuten; Efflux pump; Fatty acid glycerol ester; Intestinal transport; Non ionic surfactant; Peptide transporter

Indexed keywords

CEFTIBUTEN; ESTER; FATTY ACID GLYCEROL ESTER; POLYSORBATE 80; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; DIFFUSION CHAMBER; DRUG ABSORPTION; DRUG EFFECT; DRUG UPTAKE; INTESTINE ABSORPTION; INTESTINE BRUSH BORDER; INTESTINE MUCOSA PERMEABILITY; JEJUNUM MUCOSA; MALE; MEMBRANE VESICLE; NONHUMAN; PROTON TRANSPORT; RAT;

EID: 0032944482     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.22.402     Document Type: Article

References (22)

1. Tomita Y., Takano M., Yasuhara M., Hori R., Inui K., J. Pharmacol. Exp. Ther., 272, 63-69 (1995).
2. Sai Y., Tamai I., Sumikawa H., Hayashi K., Nakanishi T., Amano O., Numata M., Iseki S., Tsuji A., FEBS Lett., 392, 25-29 (1996).
3. Wils P., Phung-Ba V., Warnery A., Lechardeur D., Raeissi S., Hidalgo I. J., Scherman D., Biochem. Pharmacol., 48, 1528-1530 (1994).
4. Hollo Z., Homolya L., Hegedus T., Sarkadi B., FEBS Lett., 383, 99-104 (1996).
5. Saitoh H., Gerard C., Aungst B. J., J. Pharmacol. Exp. Ther., 278, 205-211 (1996).
6. Fabre J., Rudhardt M., Dayer P., Trimble E. R., Male P. J., Arzneim.-Forsch., 34, 789-791 (1984).
7. Saitoh H., Fujisaki H., Aungst B. J., Miyazaki K., Pharm. Res., 14, 645-649 (1997).
8. Naasani I., Sato K., Iseki K., Sugawara M., Kobayashi M., Miyazaki K., Biochim. Biophys. Acta, 1231, 163-168 (1995).
9. Yoshikawa T., Muranushi N., Yoshida M., Oguma T., Hirano K., Yamada H., Pharm. Res., 6, 302-307 (1989).
10. Koga K., Murakami M., Kawashima S., Biol. Pharm. Bull., 22, 103-106 (1999).
11. Nerurkar M. M., Burton P. S., Borchardt R. T., Pharm. Res., 13, 528-534 (1996).
12. Woodcock D. M., Jefferson S., Linsenmeyer M. E., Crowther P. J., Cojnowski G. M., Williams B., Bertoncello I., Cancer Res., 50, 4199-4203 (1990).
13. Feller N., Broxterman H. J., Wahrer D. C. R., Pinedo H. M., FEBS Lett., 368, 385-388 (1995).
14. Leu B. L., Huang J. D., Cancer Chemother. Pharmacol., 35, 432-436 (1995).
15. Hunter J., Hirst B. H., Simmons N. L., Pharm. Res., 10, 743-749 (1993).
16. Sagara K., Higaki K., Yamazaki A., Hashida M., Sezaki H., J. Pharmacobio-Dyn., 13, 57-63 (1990).
17. Higgins C. F., Annu. Rev. Cell Biol., 8, 67-113 (1992).
18. Zordan-Nudo T., Ling V. Liu Z., Georges E., Cancer Res., 53, 5994-6000 (1993).
19. Friche E., Jensen P. B., Sehested M., Demant E. J. F., Nissen N. N., Cancer Commun., 2, 297-303 (1990).
20. Koga K., Murakami M., Kawashima S., Biol. Pharm. Bull., 20, 674-679 (1997).
21. Wagner S., Wenzel-Seifert K., Volbracht L., Sorgenfrei D., Ebel H., Biochim. Biophys. Acta. 1190, 309-318 (1994).
22. Ollmann M., Schwarzmann G., Sandhoff K., Galla H. J., Biochemistry, 26, 5943-5952 (1987).